▶ 調査レポート

心肺自動輸血システムの世界市場(~2026年)

• 英文タイトル:Global Cardiopulmonary Autotransfusion Systems Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。心肺自動輸血システムの世界市場(~2026年) / Global Cardiopulmonary Autotransfusion Systems Market Size, Status and Forecast 2020-2026 / MRC2-11QY11271資料のイメージです。• レポートコード:MRC2-11QY11271
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は心肺自動輸血システムのグローバル市場について調査・分析したレポートです。種類別(未洗浄ATS、洗浄ATS)市場規模、用途別(心臓手術、臓器移植手術、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別心肺自動輸血システムの競争状況、市場シェア
・世界の心肺自動輸血システム市場:種類別市場規模 2015年-2020年(未洗浄ATS、洗浄ATS)
・世界の心肺自動輸血システム市場:種類別市場規模予測 2021年-2026年(未洗浄ATS、洗浄ATS)
・世界の心肺自動輸血システム市場:用途別市場規模 2015年-2020年(心臓手術、臓器移植手術、その他)
・世界の心肺自動輸血システム市場:用途別市場規模予測 2021年-2026年(心臓手術、臓器移植手術、その他)
・北米の心肺自動輸血システム市場分析:米国、カナダ
・ヨーロッパの心肺自動輸血システム市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの心肺自動輸血システム市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の心肺自動輸血システム市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの心肺自動輸血システム市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Advancis Surgical、Fresenius Kabi、Haemonetics、LivaNova、Medtronic、Terumo、Atrium Medical、Global Blood Resources、Redax、Sarstedt、Stryker
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood.
Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac. The increasing prevalence of cardiac diseases has led to rise in cardiac surgeries which has propelled the cardiopulmonary autotransfusion market globally. According to the American Heart Association, globally over 80 million people suffer from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems. Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices. Lack of availability of skilled professional for operating cardiopulmonary autotransfusion devices can restrain the growth of this market.

Market Analysis and Insights: Global Cardiopulmonary Autotransfusion Systems Market
The global Cardiopulmonary Autotransfusion Systems market size is projected to reach US$ 536.4 million by 2026, from US$ 525.6 million in 2020, at a CAGR of 1.9%% during 2021-2026.

Global Cardiopulmonary Autotransfusion Systems Scope and Market Size
Cardiopulmonary Autotransfusion Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cardiopulmonary Autotransfusion Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker

Market segment by Type, the product can be split into
Unwashed ATS
Washed ATS
Market segment by Application, split into
Heart Surgery
Great Organ Transplant Surgery
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cardiopulmonary Autotransfusion Systems Revenue
1.4 Market by Type
1.4.1 Global Cardiopulmonary Autotransfusion Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Unwashed ATS
1.4.3 Washed ATS
1.5 Market by Application
1.5.1 Global Cardiopulmonary Autotransfusion Systems Market Share by Application: 2020 VS 2026
1.5.2 Heart Surgery
1.5.3 Great Organ Transplant Surgery
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Cardiopulmonary Autotransfusion Systems Market Perspective (2015-2026)
2.2 Global Cardiopulmonary Autotransfusion Systems Growth Trends by Regions
2.2.1 Cardiopulmonary Autotransfusion Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cardiopulmonary Autotransfusion Systems Historic Market Share by Regions (2015-2020)
2.2.3 Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cardiopulmonary Autotransfusion Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Cardiopulmonary Autotransfusion Systems Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Cardiopulmonary Autotransfusion Systems Players by Market Size
3.1.1 Global Top Cardiopulmonary Autotransfusion Systems Players by Revenue (2015-2020)
3.1.2 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Cardiopulmonary Autotransfusion Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cardiopulmonary Autotransfusion Systems Market Concentration Ratio
3.2.1 Global Cardiopulmonary Autotransfusion Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cardiopulmonary Autotransfusion Systems Revenue in 2019
3.3 Cardiopulmonary Autotransfusion Systems Key Players Head office and Area Served
3.4 Key Players Cardiopulmonary Autotransfusion Systems Product Solution and Service
3.5 Date of Enter into Cardiopulmonary Autotransfusion Systems Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cardiopulmonary Autotransfusion Systems Historic Market Size by Type (2015-2020)
4.2 Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020)
5.2 Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Cardiopulmonary Autotransfusion Systems Market Size (2015-2020)
6.2 Cardiopulmonary Autotransfusion Systems Key Players in North America (2019-2020)
6.3 North America Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020)
6.4 North America Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020)

7 Europe
7.1 Europe Cardiopulmonary Autotransfusion Systems Market Size (2015-2020)
7.2 Cardiopulmonary Autotransfusion Systems Key Players in Europe (2019-2020)
7.3 Europe Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020)
7.4 Europe Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020)

8 China
8.1 China Cardiopulmonary Autotransfusion Systems Market Size (2015-2020)
8.2 Cardiopulmonary Autotransfusion Systems Key Players in China (2019-2020)
8.3 China Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020)
8.4 China Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020)

9 Japan
9.1 Japan Cardiopulmonary Autotransfusion Systems Market Size (2015-2020)
9.2 Cardiopulmonary Autotransfusion Systems Key Players in Japan (2019-2020)
9.3 Japan Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020)
9.4 Japan Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size (2015-2020)
10.2 Cardiopulmonary Autotransfusion Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020)

11 India
11.1 India Cardiopulmonary Autotransfusion Systems Market Size (2015-2020)
11.2 Cardiopulmonary Autotransfusion Systems Key Players in India (2019-2020)
11.3 India Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020)
11.4 India Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Cardiopulmonary Autotransfusion Systems Market Size (2015-2020)
12.2 Cardiopulmonary Autotransfusion Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020)
12.4 Central & South America Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Advancis Surgical
13.1.1 Advancis Surgical Company Details
13.1.2 Advancis Surgical Business Overview
13.1.3 Advancis Surgical Cardiopulmonary Autotransfusion Systems Introduction
13.1.4 Advancis Surgical Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020))
13.1.5 Advancis Surgical Recent Development
13.2 Fresenius Kabi
13.2.1 Fresenius Kabi Company Details
13.2.2 Fresenius Kabi Business Overview
13.2.3 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Introduction
13.2.4 Fresenius Kabi Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
13.2.5 Fresenius Kabi Recent Development
13.3 Haemonetics
13.3.1 Haemonetics Company Details
13.3.2 Haemonetics Business Overview
13.3.3 Haemonetics Cardiopulmonary Autotransfusion Systems Introduction
13.3.4 Haemonetics Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
13.3.5 Haemonetics Recent Development
13.4 LivaNova
13.4.1 LivaNova Company Details
13.4.2 LivaNova Business Overview
13.4.3 LivaNova Cardiopulmonary Autotransfusion Systems Introduction
13.4.4 LivaNova Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
13.4.5 LivaNova Recent Development
13.5 Medtronic
13.5.1 Medtronic Company Details
13.5.2 Medtronic Business Overview
13.5.3 Medtronic Cardiopulmonary Autotransfusion Systems Introduction
13.5.4 Medtronic Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
13.5.5 Medtronic Recent Development
13.6 Terumo
13.6.1 Terumo Company Details
13.6.2 Terumo Business Overview
13.6.3 Terumo Cardiopulmonary Autotransfusion Systems Introduction
13.6.4 Terumo Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
13.6.5 Terumo Recent Development
13.7 Atrium Medical
13.7.1 Atrium Medical Company Details
13.7.2 Atrium Medical Business Overview
13.7.3 Atrium Medical Cardiopulmonary Autotransfusion Systems Introduction
13.7.4 Atrium Medical Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
13.7.5 Atrium Medical Recent Development
13.8 Global Blood Resources
13.8.1 Global Blood Resources Company Details
13.8.2 Global Blood Resources Business Overview
13.8.3 Global Blood Resources Cardiopulmonary Autotransfusion Systems Introduction
13.8.4 Global Blood Resources Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
13.8.5 Global Blood Resources Recent Development
13.9 Redax
13.9.1 Redax Company Details
13.9.2 Redax Business Overview
13.9.3 Redax Cardiopulmonary Autotransfusion Systems Introduction
13.9.4 Redax Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
13.9.5 Redax Recent Development
13.10 Sarstedt
13.10.1 Sarstedt Company Details
13.10.2 Sarstedt Business Overview
13.10.3 Sarstedt Cardiopulmonary Autotransfusion Systems Introduction
13.10.4 Sarstedt Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
13.10.5 Sarstedt Recent Development
13.11 Stryker
10.11.1 Stryker Company Details
10.11.2 Stryker Business Overview
10.11.3 Stryker Cardiopulmonary Autotransfusion Systems Introduction
10.11.4 Stryker Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020)
10.11.5 Stryker Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Cardiopulmonary Autotransfusion Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Cardiopulmonary Autotransfusion Systems Revenue
Table 3. Ranking of Global Top Cardiopulmonary Autotransfusion Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cardiopulmonary Autotransfusion Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Unwashed ATS
Table 6. Key Players of Washed ATS
Table 7. Global Cardiopulmonary Autotransfusion Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Cardiopulmonary Autotransfusion Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Cardiopulmonary Autotransfusion Systems Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Cardiopulmonary Autotransfusion Systems Market Share by Regions (2015-2020)
Table 11. Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Cardiopulmonary Autotransfusion Systems Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Cardiopulmonary Autotransfusion Systems Market Growth Strategy
Table 17. Main Points Interviewed from Key Cardiopulmonary Autotransfusion Systems Players
Table 18. Global Cardiopulmonary Autotransfusion Systems Revenue by Players (2015-2020) (Million US$)
Table 19. Global Cardiopulmonary Autotransfusion Systems Market Share by Players (2015-2020)
Table 20. Global Top Cardiopulmonary Autotransfusion Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiopulmonary Autotransfusion Systems as of 2019)
Table 21. Global Cardiopulmonary Autotransfusion Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cardiopulmonary Autotransfusion Systems Product Solution and Service
Table 24. Date of Enter into Cardiopulmonary Autotransfusion Systems Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020) (Million US$)
Table 27. Global Cardiopulmonary Autotransfusion Systems Market Size Share by Type (2015-2020)
Table 28. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2021-2026)
Table 29. Global Cardiopulmonary Autotransfusion Systems Market Size Share by Application (2015-2020)
Table 30. Global Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020) (Million US$)
Table 31. Global Cardiopulmonary Autotransfusion Systems Market Size Share by Application (2021-2026)
Table 32. North America Key Players Cardiopulmonary Autotransfusion Systems Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Cardiopulmonary Autotransfusion Systems Market Share (2019-2020)
Table 34. North America Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020) (Million US$)
Table 35. North America Cardiopulmonary Autotransfusion Systems Market Share by Type (2015-2020)
Table 36. North America Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020) (Million US$)
Table 37. North America Cardiopulmonary Autotransfusion Systems Market Share by Application (2015-2020)
Table 38. Europe Key Players Cardiopulmonary Autotransfusion Systems Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Cardiopulmonary Autotransfusion Systems Market Share (2019-2020)
Table 40. Europe Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Cardiopulmonary Autotransfusion Systems Market Share by Type (2015-2020)
Table 42. Europe Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Cardiopulmonary Autotransfusion Systems Market Share by Application (2015-2020)
Table 44. China Key Players Cardiopulmonary Autotransfusion Systems Revenue (2019-2020) (Million US$)
Table 45. China Key Players Cardiopulmonary Autotransfusion Systems Market Share (2019-2020)
Table 46. China Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020) (Million US$)
Table 47. China Cardiopulmonary Autotransfusion Systems Market Share by Type (2015-2020)
Table 48. China Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020) (Million US$)
Table 49. China Cardiopulmonary Autotransfusion Systems Market Share by Application (2015-2020)
Table 50. Japan Key Players Cardiopulmonary Autotransfusion Systems Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Cardiopulmonary Autotransfusion Systems Market Share (2019-2020)
Table 52. Japan Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Cardiopulmonary Autotransfusion Systems Market Share by Type (2015-2020)
Table 54. Japan Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Cardiopulmonary Autotransfusion Systems Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Cardiopulmonary Autotransfusion Systems Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Cardiopulmonary Autotransfusion Systems Market Share (2019-2020)
Table 58. Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Cardiopulmonary Autotransfusion Systems Market Share by Type (2015-2020)
Table 60. Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Cardiopulmonary Autotransfusion Systems Market Share by Application (2015-2020)
Table 62. India Key Players Cardiopulmonary Autotransfusion Systems Revenue (2019-2020) (Million US$)
Table 63. India Key Players Cardiopulmonary Autotransfusion Systems Market Share (2019-2020)
Table 64. India Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020) (Million US$)
Table 65. India Cardiopulmonary Autotransfusion Systems Market Share by Type (2015-2020)
Table 66. India Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020) (Million US$)
Table 67. India Cardiopulmonary Autotransfusion Systems Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Cardiopulmonary Autotransfusion Systems Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Cardiopulmonary Autotransfusion Systems Market Share (2019-2020)
Table 70. Central & South America Cardiopulmonary Autotransfusion Systems Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Cardiopulmonary Autotransfusion Systems Market Share by Type (2015-2020)
Table 72. Central & South America Cardiopulmonary Autotransfusion Systems Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Cardiopulmonary Autotransfusion Systems Market Share by Application (2015-2020)
Table 74. Advancis Surgical Company Details
Table 75. Advancis Surgical Business Overview
Table 76. Advancis Surgical Product
Table 77. Advancis Surgical Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 78. Advancis Surgical Recent Development
Table 79. Fresenius Kabi Company Details
Table 80. Fresenius Kabi Business Overview
Table 81. Fresenius Kabi Product
Table 82. Fresenius Kabi Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 83. Fresenius Kabi Recent Development
Table 84. Haemonetics Company Details
Table 85. Haemonetics Business Overview
Table 86. Haemonetics Product
Table 87. Haemonetics Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 88. Haemonetics Recent Development
Table 89. LivaNova Company Details
Table 90. LivaNova Business Overview
Table 91. LivaNova Product
Table 92. LivaNova Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 93. LivaNova Recent Development
Table 94. Medtronic Company Details
Table 95. Medtronic Business Overview
Table 96. Medtronic Product
Table 97. Medtronic Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 98. Medtronic Recent Development
Table 99. Terumo Company Details
Table 100. Terumo Business Overview
Table 101. Terumo Product
Table 102. Terumo Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 103. Terumo Recent Development
Table 104. Atrium Medical Company Details
Table 105. Atrium Medical Business Overview
Table 106. Atrium Medical Product
Table 107. Atrium Medical Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 108. Atrium Medical Recent Development
Table 109. Global Blood Resources Business Overview
Table 110. Global Blood Resources Product
Table 111. Global Blood Resources Company Details
Table 112. Global Blood Resources Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 113. Global Blood Resources Recent Development
Table 114. Redax Company Details
Table 115. Redax Business Overview
Table 116. Redax Product
Table 117. Redax Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 118. Redax Recent Development
Table 119. Sarstedt Company Details
Table 120. Sarstedt Business Overview
Table 121. Sarstedt Product
Table 122. Sarstedt Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 123. Sarstedt Recent Development
Table 124. Stryker Company Details
Table 125. Stryker Business Overview
Table 126. Stryker Product
Table 127. Stryker Revenue in Cardiopulmonary Autotransfusion Systems Business (2015-2020) (Million US$)
Table 128. Stryker Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiopulmonary Autotransfusion Systems Market Share by Type: 2020 VS 2026
Figure 2. Unwashed ATS Features
Figure 3. Washed ATS Features
Figure 4. Global Cardiopulmonary Autotransfusion Systems Market Share by Application: 2020 VS 2026
Figure 5. Heart Surgery Case Studies
Figure 6. Great Organ Transplant Surgery Case Studies
Figure 7. Others Case Studies
Figure 8. Cardiopulmonary Autotransfusion Systems Report Years Considered
Figure 9. Global Cardiopulmonary Autotransfusion Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Cardiopulmonary Autotransfusion Systems Market Share by Regions: 2020 VS 2026
Figure 11. Global Cardiopulmonary Autotransfusion Systems Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Cardiopulmonary Autotransfusion Systems Market Share by Players in 2019
Figure 14. Global Top Cardiopulmonary Autotransfusion Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiopulmonary Autotransfusion Systems as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Cardiopulmonary Autotransfusion Systems Revenue in 2019
Figure 16. North America Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed